Newly Diagnosed Amyloid Light Chain Amyloidosis clinical trials

Explore recruiting newly diagnosed amyloid light chain amyloidosis clinical trials.

Recruiting newly diagnosed amyloid light chain amyloidosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Newly Diagnosed Amyloid Light Chain Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, open-label, randomized, dose optimization study evaluating the efficacy and safety of belantamab mafodotin administered in combination with cyclophosphamide, bortezomib, and dexamethasone in adult participants with newly diagnosed amyloid light chain amyloidosis (ALANIS)

Italy, Greece, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Newly Diagnosed Amyloid Light Chain Amyloidosis trials by city

Newly Diagnosed Amyloid Light Chain Amyloidosis in Toronto Newly Diagnosed Amyloid Light Chain Amyloidosis in Vancouver Newly Diagnosed Amyloid Light Chain Amyloidosis in Montreal Newly Diagnosed Amyloid Light Chain Amyloidosis in Calgary Newly Diagnosed Amyloid Light Chain Amyloidosis in Edmonton Newly Diagnosed Amyloid Light Chain Amyloidosis in Ottawa Newly Diagnosed Amyloid Light Chain Amyloidosis in Winnipeg Newly Diagnosed Amyloid Light Chain Amyloidosis in Quebec City Newly Diagnosed Amyloid Light Chain Amyloidosis in Hamilton Newly Diagnosed Amyloid Light Chain Amyloidosis in Kitchener Newly Diagnosed Amyloid Light Chain Amyloidosis in London Newly Diagnosed Amyloid Light Chain Amyloidosis in Halifax Newly Diagnosed Amyloid Light Chain Amyloidosis in New York Newly Diagnosed Amyloid Light Chain Amyloidosis in Los Angeles Newly Diagnosed Amyloid Light Chain Amyloidosis in Chicago Newly Diagnosed Amyloid Light Chain Amyloidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease